BioSpace News Archive

Softgel capsules are drug formulations which are unique in their packaging of the drug concentrate in a manner that increases efficiency of drug delivery.

The global organoids market is a fragmented landscape with several new players driving intense competition and rising investment in innovation.

The demand within the global market for life science microscopy devices has been rising on account of advancements in the domain of medical research and development, finds Transparency Market Research.

Transparency Market Research anticipates that the cell expansion market features fragmented vendor landscape owing to a large number of key players operating in the market.

The outsourcing of biologics has seen a tremendous rise over the years prominently due to its benefits such as decreased investment in drug development and large-scale provision of manufacturing capabilities.

Phase I/II study in patients with solid tumors expected to commence in Q3 2020 at leading sites in the United States

Called Unfold, the new company will be headquartered in the Davis, Calif., area with key operations in both the U.S. and Singapore

Innovent Biologics, Inc. jointly announced with Eli Lilly and Company that the National Medical Products Administration of China has accepted the supplemental New Drug Application for TYVYT® in combination with Gemzar® and platinum as first-line therapy in squamous non-small cell lung cancer.

Established strategic partnership with GlaxoSmithKline on Synthetic Lethality programs MAT2A, Pol Theta and Werner Helicase

Avivagen Inc., a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, is pleased to announce that it has recorded its first sale of OxC-beta™ Livestock in Brazil.